Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.02. Revenue for the quarter came in at $10.08 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• Hub Group faces credibility test as Q2 report looms Sept. 1